KRISTINA ARMISTEAD: Open Payments
NPI 1275288268 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 20 payments from 12 companies in 2025. Trend: 2023 $146 · 2024 $297 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $65 |
| Mannkind Corporation | 2 | $59 |
| Novo Nordisk Inc | 2 | $54 |
| Tandem Diabetes Care, Inc. | 1 | $50 |
| Insulet Corporation | 2 | $48 |
| Lilly USA, LLC | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Sequel Med Tech, LLC | 2 | $37 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $34 |
| CeQur Corporation | 1 | $28 |
Products named: AFREZZA, t:slim X2 Insulin Pump with Control-IQ, Omnipod, TEPEZZA, RECORLEV, TWIIST, ISTURISA, CeQur Simplicity.
Industry payments across CT — which companies pay providers there.
